Answers are grounded in this paper and cite their sources.
and breast cancer risk (OR: 1.24, 95 % CI: 1.002-1.54). However, PRS differences between patients and their first- and second-degree relatives showed strong statistical significance. The monogenic variant analysis identified 21 loss-of-function (LOF) variants in the cohort, but only one (BRCA2 9976A > T) was common among breast cancer cases. Our findings highlight the importance of within-family analysis of PRS and the challenges of applying European-derived PRS models to diverse populations.
No takes yet. Share an insight, caveat, or question.
Fateh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: